PharmaEngine Dividends and Buybacks
Dividend criteria checks 3/6
PharmaEngine is a dividend paying company with a current yield of 1.56% that is well covered by earnings.
Key information
1.6%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 2.1% |
| Dividend Growth | 10.6% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | NT$1.500 |
| Payout ratio | 58% |
Recent dividend and buyback updates
Recent updates
Would PharmaEngine, Inc. (GTSM:4162) Be Valuable To Income Investors?
Mar 30
How Much Did PharmaEngine's(GTSM:4162) Shareholders Earn From Share Price Movements Over The Last Five Years?
Feb 18Is PharmaEngine, Inc.'s (GTSM:4162) Stock On A Downtrend As A Result Of Its Poor Financials?
Jan 14
We're Not Counting On PharmaEngine (GTSM:4162) To Sustain Its Statutory Profitability
Dec 10Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 4162's dividend payments have been volatile in the past 10 years.
Growing Dividend: 4162's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| PharmaEngine Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (4162) | 1.6% |
| Market Bottom 25% (TW) | 1.7% |
| Market Top 25% (TW) | 4.5% |
| Industry Average (Biotechs) | 2.4% |
| Analyst forecast (4162) (up to 3 years) | 2.1% |
Notable Dividend: 4162's dividend (1.56%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (1.75%).
High Dividend: 4162's dividend (1.56%) is low compared to the top 25% of dividend payers in the TW market (4.5%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (58.2%), 4162's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (52.6%), 4162's dividend payments are covered by cash flows.